Japan Drug Makers Eye New Devices For Using iPS Cells To Create Drugs
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and other Japan drug makers are showing increasing interest in induced pluripotent stem cells for developing drugs for Alzheimer's and other diseases without current cures.